Table 1A.
Characteristics of the study population.
| N | Sex | Age | Smoking | Clinical diagnosis | Total IgE (IU/ml) | %FVC | %FVE1 | %Eosinophils |
Eosinophil count (cells/μl) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| (A) CHARACTERISTICS OF THE GLOBAL POPULATION | |||||||||||
| Nonallergic asthmatic subjects (NA) | 30 | 73.33% women 26.67% men |
58.03 ± 13.14* | 73.33% non-smokers 10% smokers 16.67% ex-smokers |
50% severe asthma 30% moderate asthma 20% mild asthma |
No allergic symptoms | 82.04 ± 80.63 | 81.11 ± 22.69 | 75.18 ± 22.82 | 3.83 ± 2.24 | 273.86 ± 137.13 |
| Allergic asthmatic subjects (AA) | 30 | 80% women 20% men |
42.37 ± 15.44* | 68.97% non-smokers 6.90% smokers 24.14% ex-smokers |
50% severe asthma 26.7% moderate asthma 23.3% mild asthma |
43.3% allergic to pollen 56.7% not allergic to pollen |
371.64 ± 437.69# | 75.53 ± 16.58 | 73.33 ± 16.28 | 5.70 ± 3.40 | 625.60 ± 999.28 |
% FVC, percentage of predicted value of forced vital capacity; % FEV1, percentage of predicted value of forced expiratory volume in 1 s.
*
Statistically significant comparison (P < 0.0001) between the NA and AA group.
#
Statistically significant comparison (P < 0.001) between the NA and AA group.